Add time:09/07/2019 Source:sciencedirect.com
Trilostane is a reversible, competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase, a key enzyme involved in the synthesis of steroids. It inhibits the conversion of pregnenolone to progesterone, therefore inhibiting the synthesis of progesterone and, therefore, of the adrenal, gonadal, and placental steroids derived from progesterone, including cortisol, aldosterone, androgens, and estrogens. It has been used in the treatment of Cushing's syndrome and in treating postmenopausal breast cancer when relapses have occurred in patients receiving initial estrogen receptor antagonist therapy.
We also recommend Trading Suppliers and Manufacturers of Trilostane (cas 13647-35-3). Pls Click Website Link as below: cas 13647-35-3 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View